peditrace innrennslisþykkni, lausn
fresenius kabi ab - manganosi chloridum; cupri chloridum; natrii selenas; kalii iodidum; zinci chloridum; natrii fluoridum - innrennslisþykkni, lausn
smofkabiven innrennslislyf, fleyti
fresenius kabi ab - alaninum inn; argininum inn; glycinum inn; histidinum inn; isoleucinum inn; leucinum inn; lysinum asetat; methioninum inn; phenylalaninum inn; prolinum inn; serinum inn; taurinum inn; threoninum inn; tryptophanum inn; tyrosinum inn; valinum inn; calcii chloridum; natrii glycerophosphas; magnesii sulfas; kalii chloridum; natrii acetas; zinci sulfas; glucosum; soiae oleum raffinatum; triglycerides medium chain; olivae oleum raffinatum; piscis oleum omega-3 acidis abundans - innrennslislyf, fleyti
suliqua
sanofi winthrop industrie - insúlín glargine, lixisenatide - sykursýki, tegund 2 - lyf notuð við sykursýki - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.
vaminolac innrennslislyf, lausn
fresenius kabi ab - histidinum inn; phenylalaninum inn; leucinum inn; tyrosinum inn; serinum inn; lysinum inn; cysteinum inn; glycinum inn; prolinum inn; tryptophanum inn; methioninum inn; threoninum inn; isoleucinum inn; taurinum inn; acidum glutamicum inn; valinum inn; argininum inn; acidum asparticum inn; alaninum inn - innrennslislyf, lausn
benlysta
glaxosmithkline (ireland) limited - belimumab - lupus erythematosus, systemic - Ónæmisbælandi lyf - benlysta er ætlað sem bæta-á meðferð í sjúklinga á aldrinum 5 ára og eldri með virk, mótefnamyndun jákvæð rauðir úlfar (sle) með mikla sjúkdómur starfsemi (e. , jákvæð gegn dsdna og lágt viðbót) þrátt fyrir standard meðferð. benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.
entresto
novartis europharm limited - sacubitril, valsartan - hjartabilun - ace ii hemla, önnur sturtu, umboðsmenn starfa á renín-ace kerfi - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
evotaz
bristol-myers squibb pharma eeig - cobicistat, atazanavir - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 og 5.
neparvis
novartis europharm limited - sacubitril, valsartan - hjartabilun - lyf sem hafa áhrif á renín-angíótensín kerfið - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - mergæxli - Æxlishemjandi lyf - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.